This raises the possibility that AKT2 is more important for insulin action in adipocytes than in hepatocytes, so that partial loss of its function is expressed as a predominantly “lipodystrophy-like” metabolic phenotype. The gene discussed is AKT2; the disease is lipodystrophy.